Already used off-label for psoriasis - and approved for rheumatoid arthritis and psoriatic arthritis - Amgen Inc.'s Enbrel (etanercept) won FDA approval for treating those with moderate to severe forms of the skin condition who are candidates for systemic therapy or phototherapy. (BioWorld Today)